ARKEMA INC (France) holds 1 active US FDA Type II Drug Master File and is linked to 2 FDA-registered manufacturing sites. 1 FDA enforcement record is linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “ARKEMA INC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/arkema-inc

Overview

ARKEMA INC is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering LUPEROX A75FP.

Core services & business areas

Pharmaceutical Manufacturing

API / Drug Master Files

ARKEMA INC holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • LUPEROX A75FPActive2010-02-12

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to ARKEMA INC, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

1 FDA enforcement record linked to this company.

  • 4832018-06-07

    Sample identification and other information

For suppliers

Is this ARKEMA INC?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.